Avadel Pharmaceuticals PLC
(STU:AWK)
€
9.85
0.4 (4.23%)
Market Cap: 949.15 Mil
Enterprise Value: 888.38 Mil
PE Ratio: 0
PB Ratio: 13.32
GF Score: 40/100 Avadel Pharmaceuticals PLC at SVB Leerink Global Healthcare Conference (Virtual) Transcript
Feb 24, 2021 / 08:40PM GMT
Release Date Price:
€6.95
(+6.11%)
Ami Fadia
SVB Leerink LLC, Research Division - MD of Biopharma & Generics and Senior Analyst
Good afternoon, everyone. Welcome to the next session on Avadel. As a reminder, I'm Ami Fadia. I cover biopharma and generics at SVB Leerink. And if you've got any questions that you'd like me to ask management on your behalf, please free to send it over through the dashboard.
It's my pleasure to have the Avadel team here with me today. I'd like to kick it off by asking Greg Divis, who is the CEO of the company, to give us a little bit of an overview of the company for those who are not familiar, and then we can dive into questions.
Gregory J. Divis
Avadel Pharmaceuticals plc - CEO & Director
Thanks, Ami.
Ami Fadia
SVB Leerink LLC, Research Division - MD of Biopharma & Generics and Senior Analyst
Thank you.
Gregory J. Divis
Avadel Pharmaceuticals plc - CEO & Director
Yes, thanks. And most importantly, thank you for the opportunity to participate in
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot